Journal
POSTGRADUATE MEDICINE
Volume 120, Issue 3, Pages 48-59Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3810/pgm.2008.09.1907
Keywords
attention-deficit/hyperactivity disorder; ADHD; stimulant medication; CONCERTA((R)); outcome assessment; atomoxetine; Strattera((R))
Categories
Funding
- McNeil Pediatrics, Inc.
- Ortho-McNeil Janssen Scientific Affairs, LLC
Ask authors/readers for more resources
Attention-deficit/hyperactivity disorder (ADHD) is a common, chronic, and costly disorder, with an impact that can span from preschool into adulthood. There are safe and effective therapies that can manage and help prevent many of the associated negative outcomes of ADHD, but treatment rates are far from optimal and considerable obstacles exist in achieving satisfactory treatment adherence. Individuals with untreated ADHD, their families, and other caregivers must be made aware of the impact that this disorder may have on them at every stage of life and, correspondingly, the improved outcomes that can be achieved with the successful management of ADHD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available